• Home
  • Study Details
By physician referral or invitation only

AMPLATZER Post Approval Study Registry

The Food and Drug Association (FDA) issued a Humanitarian Device Exemption (HDE) approval order for the AMPLATZERTM PIVSD Occluder on January 10, 2017. The Conditions of Approval require that St. Jude Medical (SJM) conduct a post approval study to evaluate the safety and probable benefit of the AMPLATZERTM PIVSD Occluder.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female

Contact the Team


Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

John Vavalle
Medicine - Cardiology

Study Type

Clinical or Medical

Study Topics

Heart and Circulation

IRB Number


logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.